Literature DB >> 24243341

Significant reduction of the GLUT3 level, but not GLUT1 level, was observed in the brain tissues of several scrapie experimental animals and scrapie-infected cell lines.

Yu-E Yan1, Jin Zhang, Ke Wang, Yin Xu, Ke Ren, Bao-Yun Zhang, Ming Shi, Cao Chen, Qi Shi, Chan Tian, Gang Zhao, Xiao-Ping Dong.   

Abstract

Glucose transporters 1 (GLUT1) and 3 (GLUT3) belong to the solute carrier family 2 (SLC2, facilitated glucose transporter) and are the two most important glucose transporters (GLUTs) in brain tissue, and between them, GLUT3 is the primary one for neurons, which is responsible for glucose uptake. To obtain insights into the possible alterations of GLUT1 and GLUT3 in transmissible spongiform encephalopathies (TSEs), the protein levels of GLUT1 and GLUT3 in the brain tissues of agents 263K- and 139A-infected hamsters, as well as agents 139A- and ME7-infected mice, were evaluated. Western blots, immunofluorescent assay (IFA), and immunohistochemical (IHC) assays revealed that at the terminal stages of the infection, GLUT3 level in the brain tissues of scrapie-infected rodents was significantly downregulated, while GLUT1 level remained almost unchanged. The decline of GLUT3 level was closely related with prolonged incubation time. In line with these results in vivo, the GLUT3 level in a prion persistently infected cell line SMB-S15 was also lower than that of its normal cell line SMB-PS. Moreover, the level of hypoxia-inducible factor-1 alpha (HIF-1α), which positively regulated the expressions of GLUTs, was also markedly downregulated in the brains of several scrapie-infected animals. In vitro glucose uptake assays illustrated a markedly decreased 2-[N-(7-nitrobenze-2-oxa-1,3-diazol-4-yl)amino]-2-deoxyglucose uptake activity in SMB-S15 cells. Our data indicate that the reduction of GLUT3 is a common phenomenon in prion diseases, which occurs much earlier than the appearance of clinical symptoms. Defect in glucose uptake and metabolism of neurons, like in other neurodegenerative diseases, for example, Alzheimer's disease (AD), may be one of the essential processes in the pathogenesis of prion diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24243341     DOI: 10.1007/s12035-013-8574-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  62 in total

1.  Multiplication of the scrapie agent.

Authors:  D A Haig; M C Clarke
Journal:  Nature       Date:  1971-11-12       Impact factor: 49.962

Review 2.  Is there an astrocyte-neuron ketone body shuttle?

Authors:  M Guzmán; C Blázquez
Journal:  Trends Endocrinol Metab       Date:  2001 May-Jun       Impact factor: 12.015

3.  Synthetic mammalian prions.

Authors:  Giuseppe Legname; Ilia V Baskakov; Hoang-Oanh B Nguyen; Detlev Riesner; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  Science       Date:  2004-07-30       Impact factor: 47.728

Review 4.  Glucose metabolism and insulin receptor signal transduction in Alzheimer disease.

Authors:  Siegfried Hoyer
Journal:  Eur J Pharmacol       Date:  2004-04-19       Impact factor: 4.432

5.  Different expression patterns of CK2 subunits in the brains of experimental animals and patients with transmissible spongiform encephalopathies.

Authors:  Jian-Ming Chen; Chen Gao; Qi Shi; Bing Shan; Yan-Jun Lei; Chen-Fang Dong; Run An; Gui-Rong Wang; Bao-Yun Zhang; Jun Han; Xiao-Ping Dong
Journal:  Arch Virol       Date:  2008-04-11       Impact factor: 2.574

6.  Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease.

Authors:  Ying Liu; Fei Liu; Khalid Iqbal; Inge Grundke-Iqbal; Cheng-Xin Gong
Journal:  FEBS Lett       Date:  2008-01-02       Impact factor: 4.124

7.  Cellular localization and characterization of Glut 3 glucose transporter isoform in human brain.

Authors:  G J Mantych; D E James; H D Chung; S U Devaskar
Journal:  Endocrinology       Date:  1992-09       Impact factor: 4.736

8.  Diminished glucose transport in Alzheimer's disease: dynamic PET studies.

Authors:  W J Jagust; J P Seab; R H Huesman; P E Valk; C A Mathis; B R Reed; P G Coxson; T F Budinger
Journal:  J Cereb Blood Flow Metab       Date:  1991-03       Impact factor: 6.200

Review 9.  An overview of human prion diseases.

Authors:  Muhammad Imran; Saqib Mahmood
Journal:  Virol J       Date:  2011-12-24       Impact factor: 4.099

10.  CREB regulates the expression of neuronal glucose transporter 3: a possible mechanism related to impaired brain glucose uptake in Alzheimer's disease.

Authors:  Nana Jin; Wei Qian; Xiaomin Yin; Lan Zhang; Khalid Iqbal; Inge Grundke-Iqbal; Cheng-Xin Gong; Fei Liu
Journal:  Nucleic Acids Res       Date:  2013-01-22       Impact factor: 16.971

View more
  7 in total

1.  Decrease of RyR2 in the prion infected cell line and in the brains of the scrapie infected mice models and the patients of human prion diseases.

Authors:  Qi Shi; Jian-Le Li; Yue Ma; Li-Ping Gao; Kang Xiao; Jing Wang; Wei Zhou; Cao Chen; Yan-Jun Guo; Xiao-Ping Dong
Journal:  Prion       Date:  2018-06-07       Impact factor: 3.931

2.  Different Aberrant Changes of mGluR5 and Its Downstream Signaling Pathways in the Scrapie-Infected Cell Line and the Brains of Scrapie-Infected Experimental Rodents.

Authors:  Chao Hu; Cao Chen; Ying Xia; Jia Chen; Wei Yang; Lin Wang; Dong-Dong Chen; Yue-Zhang Wu; Qin Fan; Xiao-Xi Jia; Kang Xiao; Qi Shi; Zhi-Bao Chen; Xiao-Ping Dong
Journal:  Front Cell Dev Biol       Date:  2022-05-12

3.  Activation of the AMPK-ULK1 pathway plays an important role in autophagy during prion infection.

Authors:  Xue-Yu Fan; Chan Tian; Hui Wang; Yin Xu; Ke Ren; Bao-Yun Zhang; Chen Gao; Qi Shi; Ge Meng; Lu-Bin Zhang; Yang-Jing Zhao; Qi-Xiang Shao; Xiao-Ping Dong
Journal:  Sci Rep       Date:  2015-10-01       Impact factor: 4.379

4.  Prion protein modulates glucose homeostasis by altering intracellular iron.

Authors:  Ajay Ashok; Neena Singh
Journal:  Sci Rep       Date:  2018-04-26       Impact factor: 4.379

5.  Expression of GLUT3 and HIF-1α in Meningiomas of Various Grades Correlated with Peritumoral Brain Edema.

Authors:  Tao Mei; Zhengjun Wang; Jianwu Wu; Xianhua Liu; Wei Tao; Shousen Wang; Fuyong Chen
Journal:  Biomed Res Int       Date:  2020-08-29       Impact factor: 3.411

6.  Significant enhanced expressions of aquaporin-1, -4 and -9 in the brains of various prion diseases.

Authors:  Qi Shi; Yue-Zhang Wu; Xuehua Yang; Kang Xiao; Adalaiti Maimaitiming; Li-Ping Gao; Cao Chen; Chen Gao; Yanjun Guo; Xiao-Ping Dong
Journal:  Prion       Date:  2019-01       Impact factor: 3.931

7.  Expression and Prognostic Value of Glucose Transporter 3 in Diffuse Large B Cell Lymphoma.

Authors:  Yongpeng Xu; Xinglu Zhou; Shuai Zhang; Abiyasi Nanding; Qijia Xuan
Journal:  Onco Targets Ther       Date:  2022-02-25       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.